Journal of Cancer Research and Clinical Oncology

, Volume 135, Issue 11, pp 1593–1599 | Cite as

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients

  • Myong Cheol Lim
  • Sokbom Kang
  • Sang-Soo Seo
  • Sun-Young Kong
  • Bo-Yon Lee
  • Seon-Kyung Lee
  • Sang-Yoon Park
Original Paper

Abstract

Purpose

To evaluate the proportion of Korean ovarian cancer patients with a strong family history and the genetic status in such patients.

Methods and patients

Pedigree analysis and genetic counseling were performed on 337 ovarian cancer patients in the National Cancer Center Korea between January 2005 and June 2008. Patients with a strong family history were defined as (1) patients with double primary ovarian and breast cancer and (2) ovarian cancer patients with one or more first-degree relatives with breast or ovarian cancer. Lymphocyte specimens from peripheral blood were processed for BRCA1 and BRCA2 by direct sequencing.

Results

Sixteen percent (54/337) of patients had a strong family history. Of the 54 patients with a strong family history, 40 patients (74%) accepted the genetic test. Thirteen deleterious mutations (11 in BRCA1 and 2 in BRCA2) were identified (33%). Twenty-three of 283 patients (8%) without a strong family history underwent genetic testing and two deleterious mutations in BRCA1 were identified (9%). Eight of 15 mutations (53%) were novel, and c.1041delAGCinsT and c.2081insC in the BRCA1 gene were recurrent in two patients.

Conclusions

The proportion of Korean ovarian cancer patients with a strong family history was significant, and the prevalence of BRCA1 and BRCA2 mutations in such patients was high.

Keywords

BRCA1 BRCA2 Ovarian cancer Germline mutation Genetics 

References

  1. Ahn SH, Hwang UK, Kwak BS, Yoon HS, Ku BK, Kang HJ, Kim JS, Ko BK, Ko CD, Yoon KS, Cho DY, Kim JS, Son BH (2004) Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci 19:269–274PubMedGoogle Scholar
  2. Ahn SH, Son BH, Yoon KS, Noh DY, Han W, Kim SW, Lee ES, Park HL, Hong YJ, Choi JJ, Moon SY, Kim MJ, Kim KH, Kwak BS, Cho DY (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90–95. doi:10.1016/j.canlet.2005.12.031 PubMedCrossRefGoogle Scholar
  3. Berek JS, Natarajan S (2007) Ch 35. Ovarian and Fallopian Tube Cancer, 14th edn. Lippincott, Philadelphia, pp 1457–1547Google Scholar
  4. Booth M, Beral V, Smith P (1989) Risk factors for ovarian cancer: a case-control study. Br J Cancer 60:592–598PubMedGoogle Scholar
  5. Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283:2260–2265. doi:10.1001/jama.283.17.2260 PubMedCrossRefGoogle Scholar
  6. Choi DH, Lee MH, Bail AE, Carter D, Haffy BG (2003) Distint patterns of BRCA1 and BRCA2 mutations in Korean women with early-onset breast cancer. Cancer Res Treat 35:3sGoogle Scholar
  7. Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638–1645. doi:10.1200/JCO.2004.04.179 PubMedCrossRefGoogle Scholar
  8. Chung HH, Hwang SY, Jung KW, Won YJ, Shin HR, Kim JW, Lee HP (2007) Ovarian cancer incidence and survival in Korea: 1993–2002. Int J Gynecol Cancer 17:595–600. doi:10.1111/j.1525-1438.2007.00824.x PubMedCrossRefGoogle Scholar
  9. de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodriguez R, Diaz-Rubio E, Benitez J, Devilee P, Caldes T (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466–471. doi:10.1002/ijc.1627 PubMedCrossRefGoogle Scholar
  10. Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE (2007) A systematic genetic assessment of 1, 433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81:873–883. doi:10.1086/521032 PubMedCrossRefGoogle Scholar
  11. Kang HC, Kim IJ, Park JH, Kwon HJ, Won YJ, Heo SC, Lee SY, Kim KH, Shin Y, Noh DY, Yang DH, Choe KJ, Lee BH, King SB, Park JG (2002) Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families. Hum Mutat 20:235. doi:10.1002/humu.9059 PubMedCrossRefGoogle Scholar
  12. Katagiri T, Kasumi F, Yoshimoto M, Nomizu T, Asaishi K, Abe R, Tsuchiya A, Sugano M, Takai S, Yoneda M, Fukutomi T, Nanba K, Makita M, Okazaki H, Hirata K, Okazaki M, Furutsuma Y, Morishita Y, Iino Y, Karino T, Ayabe H, Hara S, Kajiwara T, Houga S, Miki Y et al (1998) High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J Hum Genet 43:42–48. doi:10.1007/s100380050035 PubMedCrossRefGoogle Scholar
  13. Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H (2000) Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 16:88–89. doi:10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G PubMedCrossRefGoogle Scholar
  14. Kim YT, Nam EJ, Yoon BS, Kim SW, Kim SH, Kim JH, Kim HK, Koo JS, Kim JW (2005) Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Gynecol Oncol 99:585–590. doi:10.1016/j.ygyno.2005.06.058 PubMedCrossRefGoogle Scholar
  15. Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS (2006) Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol Biomarkers Prev 15:359–363. doi:10.1158/1055-9965.EPI-05-0687 PubMedCrossRefGoogle Scholar
  16. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413–424. doi:10.1002/humu.10154 PubMedCrossRefGoogle Scholar
  17. Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71:595–606. doi:10.1086/342506 PubMedCrossRefGoogle Scholar
  18. Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL (2001) Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:2247–2253PubMedGoogle Scholar
  19. Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415–422. doi:10.1002/humu.20169 PubMedCrossRefGoogle Scholar
  20. Meindl A (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472–480. doi:10.1002/ijc.1626 PubMedCrossRefGoogle Scholar
  21. Menkiszak J, Gronwald J, Gorski B, Jakubowska A, Huzarski T, Byrski T, Foszczynska-Kloda M, Haus O, Janiszewska H, Perkowska M, Brozek I, Grzybowska E, Zientek H, Gozdz S, Kozak-Klonowska B, Urbanski K, Miturski R, Kowalczyk J, Pluzanska A, Niepsuj S, Koc J, Szwiec M, Drosik K, Mackiewicz A, Lamperska K, Strozyk E, Godlewski D, Stawicka M, Wasko B, Bebenek M, Rozmiarek A, Rzepka-Gorska I, Narod SA, Lubinski J (2003) Hereditary ovarian cancer in Poland. Int J Cancer 106:942–945. doi:10.1002/ijc.11338 PubMedCrossRefGoogle Scholar
  22. Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U, Ben-Baruch G, Fishman A, Menczer J, Ebbers SM, Tucker MA, Wacholder S, Struewing JP, Friedman E, Piura B (2001) Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 345:235–240. doi:10.1056/NEJM200107263450401 PubMedCrossRefGoogle Scholar
  23. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259–1272. doi:10.1086/302853 PubMedCrossRefGoogle Scholar
  24. Narod SA (2005) Clinical genetics of gynecologic cancer, 4th edn. Lippincott, PhiladelphiaGoogle Scholar
  25. Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807–2816. doi:10.1002/cncr.21536 PubMedCrossRefGoogle Scholar
  26. Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, Shakoori AR, Seidel-Renkert A, Farooq H, Narod S, Amin A, Hamann U (2006) Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer 119:2832–2839. doi:10.1002/ijc.22269 PubMedCrossRefGoogle Scholar
  27. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710. doi:10.1086/318787 PubMedCrossRefGoogle Scholar
  28. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706PubMedCrossRefGoogle Scholar
  29. Russo A, Calo V, Bruno L, Rizzo S, Bazan V, Di Fede G (2009) Hereditary ovarian cancer. Crit Rev Oncol Hematol 69:28–44. doi:10.1016/j.critrevonc.2008.06.003 PubMedCrossRefGoogle Scholar
  30. Sarantaus L, Vahteristo P, Bloom E, Tamminen A, Unkila-Kallio L, Butzow R, Nevanlinna H (2001) BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients. Eur J Hum Genet 9:424–430. doi:10.1038/sj.ejhg.5200652 PubMedCrossRefGoogle Scholar
  31. Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7:3144–3150PubMedGoogle Scholar
  32. Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM, Lee HS, Choe JJ, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Son GS, Lee JB, Koo BH (2004) BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Hum Mutat 24:350. doi:10.1002/humu.9275 PubMedCrossRefGoogle Scholar
  33. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020PubMedGoogle Scholar
  34. Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ (2000) Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 78:148–151. doi:10.1006/gyno.2000.5848 PubMedCrossRefGoogle Scholar
  35. Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D (1999) Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin Genet 55:318–324. doi:10.1034/j.1399-0004.1999.550504.x PubMedCrossRefGoogle Scholar
  36. Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E (2000) Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86:737–740. doi:10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Myong Cheol Lim
    • 1
  • Sokbom Kang
    • 1
  • Sang-Soo Seo
    • 1
  • Sun-Young Kong
    • 2
  • Bo-Yon Lee
    • 3
  • Seon-Kyung Lee
    • 4
  • Sang-Yoon Park
    • 1
  1. 1.Center for Uterine Cancer, Research Institute and HospitalNational Cancer CenterGoyang-siKorea
  2. 2.Department of Laboratory Medicine, Center for Clinical Services, Research Institute and HospitalNational Cancer CenterGoyang-siKorea
  3. 3.Department of Obstetrics and Gynecology, Kyung-Hee University Medical CenterKyung-Hee UniversitySeoulKorea
  4. 4.Department of Obstetrics and Gynecology, East-West Neo Medical CenterKyung-Hee UniversitySeoulKorea

Personalised recommendations